Document Type
Original Article
Abstract
Background: The importance of accurately measuring glycemic control in the diabetic people cannot be overstated, since better glycemic control decreases micro- and macrovascular problems in individuals with diabetes mellitus getting renal replacement treatment. Aim: This study's objective was to contrast between glycated hemoglobin and glycated albumin in diabetes in hemodialysis patients. Subject and Methods: This was Prospective Comparative research caried out on 100 diabetic patients. Two groups were created out of them: Group (I): that had 50 patients’ diabetic on hemodialysis. Group (II): that included 50 patients diabetic not on hemodialysis. From March 2022 to September 2022, this research was carried out in the Nephrology Hemodialysis unit at Al-Azhar Hospital. Results: The current research indicated a great statistically substantial enhancement in GA level among group I in comparison with group II (7.2±9.1 vs. 1.8±1.8 %, respectively) while there was a statistically substantial reduce in HbA1C level among group I in comparison with group II (6.9±1.6 vs. 7.7±1.3 %, respectively) (P value
Keywords
diabetes, hemodialysis, glycemic control, GA, HbA1C.
Subject Area
Internal Medicine
How to Cite This Article
Rashed, AlSayed Mohamed; Mohamed, Reda Fakhry; Ghabsha, Mohamed Alsayed Abo; and Ghoneim, Mohamed Shehata Shaaban
(2023)
"Comparative Study between Glycated Hemoglobin and Glycated Albumin in Diabetes in Hemodialysis Patients,"
Al-Azhar International Medical Journal: Vol. 4:
Iss.
8, Article 37.
DOI: https://doi.org/10.58675/2682-339X.1924